An oncologist, cancer researcher and author recently shared a study that chemotherapy-resistant turbo cancers caused by Pfizer and Moderna Wuhan coronavirus (COVID-19) mRNA vaccines can be overcome by Ivermectin, a controversial anti-parasitic drug known to ease symptoms of viruses such as coronavirus. Health authorities have been debunking this information and have not authorised or approved its use in humans.

Dr William Makis cited a paper from 2020 (by Juarez et al.) on the anti-tumour effects of Ivermectin at clinically feasible concentrations, where it was found to support its clinical development as a re-positioned cancer drug.

According to the study, at a human dose of two mg/kg, Ivermectin can achieve anti-cancer effects such as cell cycle arrest (inhibit proliferation), preferential inhibition of cancer stem-like cells, synergy with several chemotherapy drugs, and inhibition of tumour growth in a breast cancer mouse model.

Ivermectin was tested at two mg/kg/day, which is roughly 5uM in vitro concentration. The researchers found that the drug targets cancer stem cells, which tend to be resistant to chemotherapy.

"Ivermectin has a preferential depletion effect on the cancer stem-like cell population," the authors included in the research. "We observed that among all the evaluated cell lines, a decrease in cell viability and clonogenicity is more evident in the cancer stem-like cells than in their parental population."

It also found that the most sensitive cancer cell lines were the ovarian, breast, glioblastoma (brain), lung, colon, uterine squamous cell carcinoma (SCC), hepatocellular, triple-negative breast cancer (TNBC), pancreatic and endometrial.

Meanwhile, the least sensitive were osteosarcoma, gastric and melanoma.

Moreover, lymphoma and leukaemia cell lines appear to be more resistant to Ivermectin, but the drug significantly impacts those cells' ability to form colonies, according to the study. (Related: Health experts suggest that Ivermectin can "kill cancer cells" and boost immune response.)

Makis further highlighted that this was the first study he had ever seen that had tested as many as 28 cancer types with Ivermectin. "No wonder it's hidden from the public," he commented.

In March 2022, the U.S. Food and Drug Administration (FDA) agreed to permanently remove its social media posts urging people to avoid using for COVID-19.

The agency removed a page that said, "Should I take Ivermectin to prevent or treat COVID-19? No." It also took down posts, including one that reads, "You are not a horse. You are not a cow. Seriously, y'all. Stop it."

The move was made following a lawsuit with a settlement filed with a federal court in Texas that ordered the agency to delete another page titled "Why you should not use Ivermectin to treat or prevent COVID-19 within 21 days."

The article said Ivermectin was neither authorised nor approved to prevent or treat COVID-19 in humans or animals. It also claimed that evidence does not support its efficacy against coronavirus.

On 02 Jun 2022, Doctors Paul Marik, Mary Talley Bowden and Robert Apter filed a lawsuit against the FDA and its secretary, Robert Califf, and the Department of Health and Human Services and its secretary, Xavier Becerra. They accused the FDA of meddling with their capacity to practice medicine. The lawsuit was first turned down because the FDA has "sovereign immunity." However, the U.S. Court of Appeals for the Fifth Circuit overruled the lower court's ruling, stating that the "FDA is not a physician" and "even tweet-sized doses of personalised medical advice are beyond the FDA's statutory authority."

Ivermectin has long been approved for use in both animals and humans. In cases of humans, the drug is recommended to treat parasitic infections such as river blindness disease, thread-worm infestation, tropical eosinophilia, roundworm infestation, whip-worm infestation, filariasis (also called elephantiasis) and loiasis (a parasitic infection spread by biting flies in West and Central African rain-forests).

On X, formerly Twitter, Dr Mary Talley Bowden wrote: "This landmark case sets an important precedent in limiting FDA overreach into the doctor-patient relationship."

Moreover, independent presidential candidate Robert F. Kennedy Jr. tweeted: "The FDA is biased against many low-cost, generic, and natural therapies with low-profit potential. Could it be because half its funding comes from Big Pharma?"

Australian politician Craig Kelly called the FDA "corrupt," stating they have "blood on their hands."

30 Aug 2024

Source